title: Quality of life and impairment in patients with multiple sclerosis.
abstract: OBJECTIVE
  The aims of this study were to describe the quality of life in patients with multiple sclerosis (MS) given immunological treatment and in those not given immunological treatment and to investigate the relationship between impairment and quality of life.
  
  
  METHODS
  Twenty nine patients given immunological treatment were matched with the same number of patients not given such treatment. Matching variables were sex, Kurtzke's Expanded Disability Status Scale (EDSS), years since diagnosis, and age (total n = 58). The patients were interviewed using the self-reported impairment checklist and they answered two questionnaires on quality of life, the 36-Item Short-Form Health Survey (SF-36) and the Subjective Estimation of Quality of Life (SQoL).
  
  
  RESULTS
  The self-reported impairment checklist captured a more differentiated picture of the patients' symptoms of MS than the EDSS. Health related quality of life was markedly reduced, while the subjective quality of life was less affected. There was a stronger association between self-reported ratings of impairment and health related quality of life on the SF-36 than between impairment and global ratings of quality of life on the SQoL. Subjective quality of life on the SQoL was not directly dependent on impairment expressed in physical limitations. There were no statistically significant differences between the treated and untreated groups. A non-significant trend towards better health related quality of life was found in favour of the treated group with respect to emotional role, physical role, and social function on the SF-36.
  
  
  CONCLUSIONS
  The self-reported impairment checklist and SF-36 proved to be valuable complements to the well established EDSS in describing the diverse symptoms of MS. Measuring both health related quality of life and subjective wellbeing provides valuable knowledge about the consequences of MS.
authors.affiliation: Department of Caring Sciences, University of Orebro, S-701 82 Orebro, Sweden. ann-kristin.isaksson@ivo.oru.se
authors.forename: A-K
authors.initials: AK
authors.lastname: Isaksson
authors.forename: G
authors.initials: G
authors.lastname: Ahlström
authors.forename: L-G
authors.initials: LG
authors.lastname: Gunnarsson
mesh_terms: D000203:Activities of Daily Living; D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D005260:Female; D006304:Health Status; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy / Q000523:psychology*; D011788:Quality of Life / Q000523:psychology*
chemical_list: D000276:Adjuvants, Immunologic